Search results
Results from the WOW.Com Content Network
Rheumatoid arthritis. Ehlers-Danlos Syndrome. Sarcoidosis. Scleroderma. Systemic lupus erythematosus. Temporal arteritis. Relapsing polychondritis. Granulomatosis with polyangiitis 50-60% have ophthalmologic manifestations, which can be a presenting feature in a minority of patients.
Specialty. Oncology. An eye neoplasm is a tumor of the eye. [ 1] A rare type of tumor, [ 2] eye neoplasms can affect all parts of the eye, and can either be benign or malignant ( cancerous ), in which case it is known as eye cancer. [ 3] Eye cancers can be primary (starts within the eye) or metastatic cancer (spread to the eye from another organ).
Treatment. Immunosuppression. Cancer Associated Retinopathy (CAR) also known as Carcinoma Associated Retinopathy is an immune-mediated disease affecting the retina of the eye. It is a paraneoplastic type autoimmune retinopathy associated with cancer that can cause blindness. It can be seen in association with various types of cancers.
Autoimmune retinopathy. Autoimmune retinopathy (AIR) is a rare disease in which the patient 's immune system attacks proteins in the retina, leading to loss of eyesight. The disease is poorly understood, but may be the result of cancer or cancer chemotherapy. [1] The disease is an autoimmune condition characterized by vision loss, blind spots ...
8.7% global prevalence in 2020 [ 2] Macular degeneration, also known as age-related macular degeneration ( AMD or ARMD ), is a medical condition which may result in blurred or no vision in the center of the visual field. [ 1] Early on there are often no symptoms. [ 1] Over time, however, some people experience a gradual worsening of vision that ...
Symptomatic features of paraneoplastic syndrome cultivate in four ways: endocrine, neurological, mucocutaneous, and hematological.The most common presentation is a fever (release of endogenous pyrogens often related to lymphokines or tissue pyrogens), but the overall picture will often include several clinical cases observed which may specifically simulate more common benign conditions.
For example, various Global Burden of Disease Studies investigate such factors and quantify recent developments – one such systematic analysis analyzed the (non)progress on cancer and its causes during the 2010-19 decade, indicating that 2019, ~44% of all cancer deaths – or ~4.5 M deaths or ~105 million lost disability-adjusted life years ...
Cancer diagnoses in adults under 50, while increasing, are still rare, and U.S. cancer deaths have been declining thanks to fewer people smoking tobacco and better treatment.